Nutritional factors and anticonvulsant therapies: effect on growth in children with epilepsy

H L Kurowski1, S M Gospe, F J Zeman

  • 1Department of Nutrition, University of California, Davis 95616.

Insights

Epileptic children taking carbamazepine or valproic acid showed normal linear growth. Low dietary zinc intake did not impact height, and medication duration did not affect weight in this study.

Area of Science:

  • Pediatric Endocrinology
  • Neurodevelopmental Disorders
  • Clinical Nutrition

Background:

  • Epilepsy affects children's growth and development.
  • Anticonvulsant medications like carbamazepine and valproic acid may influence growth parameters.
  • Nutritional factors, including zinc intake, are crucial for child development.

Purpose of the Study:

  • To investigate the factors influencing growth in epileptic children before puberty.
  • To compare growth and nutritional status between children taking carbamazepine versus valproic acid.
  • To assess the impact of dietary zinc intake and anticonvulsant therapy on linear growth and weight.

Main Methods:

  • Cross-sectional study of 32 epileptic children, divided into carbamazepine and valproic acid groups.
  • Assessment of dietary intake (energy, iron, zinc), hemoglobin, and serum zinc.
  • Comparison of height and weight with National Center for Health Statistics growth charts.
  • Statistical analyses including Student's t test, ANCOVA, and stepwise regression.

Main Results:

  • No significant differences in height or weight were observed between the two drug groups.
  • Linear growth was within normal ranges for all participants.
  • Low dietary zinc intake (64-87% RDA) was not associated with reduced height.
  • Neither duration nor total intake of anticonvulsants significantly affected weight, contrary to expectations for valproic acid.

Conclusions:

  • Carbamazepine and valproic acid did not significantly impact linear growth or weight in this cohort of epileptic children.
  • Dietary zinc intake, even when below recommendations, did not impede height.
  • Further research is needed to understand the weight-regulating mechanisms of valproic acid in pediatric epilepsy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...